Jane Green

Senior Strategist

Jane is an accomplished communications executive with more than 20 years of leadership experience in creating, implementing and directing intelligent, innovative and result-oriented strategic communications programs for private and publicly traded life sciences companies.

Jane has held senior executive positions working as an integral member of senior management teams in a diversity of biopharmaceutical companies. She has worked in close collaboration with chief executive and chief financial officers in companies with pioneering and controversial technology and drug discovery platforms such as antisense (Isis Pharmaceuticals), microfluidics (Caliper Technologies), kinase-based drug discovery (Exelixis), toll-like receptor immune modulators (Dynavax), and Hsp90 inhibitors (Kosan), to name a few.

As a strategic communications consultant, she has provided intelligent, rigorous and effective counsel to private and publicly-traded companies undergoing transformational events, including: clinical, regulatory or commercial successes or setbacks; product launches and withdrawals; financings in optimal as well as distressed circumstances; mergers, acquisitions and major corporate transactions; securities and patent litigation; management turnover; corporate restructuring; and corporate rebranding and identity management. She has expertise in every critical area of public affairs, corporate communications and investor relations.

Jane is well-known and respected throughout the life sciences industry and within the healthcare investor, equity research and investment banking communities. She enjoys an excellent reputation for integrity, discretion and professionalism.